Bristol Myers Squibb announced results from the Phase 3 VALOR-HCM study, which showed the addition of mavacamten, an investigational, first-in-class cardiac myosin inhibitor, significantly...
Global technology firm Digital Intelligence Systems, LLC (DISYS) announced a partnership with ComplianceQuest, the leading provider of 100% cloud-native, AI-powered, Enterprise Clinical, Quality Health,...
Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced it has expanded its presence in the Rocky Mountain...
Hendrix Genetics (the "Company"), a leading multi-species animal genetics and technology company and Paine Schwartz Partners, a global leader in sustainable food chain investing,...
Scenic Biotech BV ('Scenic' or 'the Company'), a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for...
